Patents by Inventor Laurent Fischer

Laurent Fischer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090148538
    Abstract: Disclosed herein is the use of adsorbent carbon microspheres for the treatment of pouchitis.
    Type: Application
    Filed: October 10, 2008
    Publication date: June 11, 2009
    Applicant: Ocera Therapeutics, Inc.
    Inventors: Laurent Fischer, Matthew Scott Harris
  • Publication number: 20070141045
    Abstract: Adsorbent carbon microspheres are administered to treat irritable bowel syndrome or symptoms associated with irritable bowel syndrome.
    Type: Application
    Filed: December 5, 2006
    Publication date: June 21, 2007
    Inventors: Akiko Shibata, Laurent Fischer
  • Publication number: 20060122142
    Abstract: DNA vaccine against a pathogen affecting farm animals, in particular bovines or porcines, comprising a plasmid containing a nucleotide sequence encoding an immunogen of a pathogen of the animal species considered, under conditions allowing the in vivo expression of this sequence, and a cationic lipid containing a quaternary ammonium salt, of formula in which R1 is a saturated or unsaturated linear aliphatic radical having 12 to 18 carbon atoms, R2 is another aliphatic radical containing 2 or 3 carbon atoms, and X a hydroxyl or amine group, this lipid being preferably DMRIE.
    Type: Application
    Filed: January 30, 2006
    Publication date: June 8, 2006
    Inventors: Jean-Christophe Audonnet, Laurent Fischer, Simona Barzu-Le-Roux
  • Publication number: 20060004186
    Abstract: Substantially purified salivary P. ariasi and P. perniciosus polypeptides, and polynucleotides encoding these polypeptides are disclosed. Vectors and host cells including the P. ariasi and P. perniciosus polynucleotides are also disclosed. In one embodiment, a method is disclosed for inducing an immune response to sand fly saliva. In other embodiments, methods for treating or preventing Leishmaniasis are disclosed.
    Type: Application
    Filed: September 18, 2003
    Publication date: January 5, 2006
    Inventors: Jesus Valenzuela, Jose Ribiero, Shaden Kamhawi, Yasmine Belkaid, Laurent Fischer, Jean-Christophe Audonnet, Francis Milward
  • Publication number: 20050164946
    Abstract: The present invention relates to a canine pre-proGHRH polypeptide, a canine mature GHRH peptide, an isolated polynucleotide which encodes the canine pre-proGHRH or the canine mature GHRH. The invention also encompasses vectors encoding and expressing the canine pre-proGHRH or the canine GHRH which can be used to treat disease and growth hormone deficiencies by gene therapy in vertebrates, in particular in dogs.
    Type: Application
    Filed: December 17, 2004
    Publication date: July 28, 2005
    Inventors: Laurent Fischer, Nathalie Cachet, Simona Barzu-Le-Roux
  • Patent number: 6156567
    Abstract: Recombinant adenoviruses, methods of making them, uses for them, including in immunological, immunogenic, vaccine or therapeutic compositions, or, as a vector for cloning, replicating or expressing DNA and methods of using the compositions and vector, expression products from them, and uses for the expression products are provided. More particularly, recombinant canine adenoviruses (CAV) and methods of making them, uses for them, expression products from them, and uses for the expression products, including recombinant CAV2 viruses are provided. Additionally, truncated promoters, expression cassettes containing the promoters, and recombinant viruses and plasmids containing the promoters or expression cassettes are provided.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: December 5, 2000
    Assignee: Merial
    Inventor: Laurent Fischer
  • Patent number: 6090393
    Abstract: Disclosed and claimed are recombinant adenoviruses, methods of making them, uses for them (including in immunological, immunogenic, vaccine or therapeutic compositions, or, as a vector for cloning, replicating or expressing DNA and methods of using the compositions and vector), expression products from them, and uses for the expression products. More particularly, disclosed and claimed are recombinant canine adenoviruses (CAV) and methods of making them, uses for them, expression products from them, and uses for the expression products, including recombinant CAV2 viruses. Additionally, disclosed and claimed are truncated promoters, expression cassettes containing the promoters, and recombinant viruses and plasmids containing the promoters or expression cassettes.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: July 18, 2000
    Assignee: Merial
    Inventor: Laurent Fischer
  • Patent number: 5989561
    Abstract: Attenuated recombinant viruses containing DNA encoding a calicivirus antigen such as a RHDV antigen, e.g., a capsid gene, as well as methods and compositions employing the viruses, expression products therefrom, and antibodies generated from the viruses or expression products, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The recombinant viruses and gene products therefrom and antibodies generated by the viruses and gene products have several preventive, therapeutic and diagnostic uses. The DNA from the viruses can be used for probes or for primers.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 23, 1999
    Assignee: Virogenetics Corporation
    Inventors: Enzo Paoletti, Laurent Fischer, Francois-Xavier Legros
  • Patent number: 5888597
    Abstract: The invention relates to a packaging comprising a thermoplastic film based on a polymer containing polyamide blocks and polyether blocks, said polymer being permeable to water vapor, to ethylene, to CO.sub.2 and to oxygen, such that the permeability to CO.sub.2 is very much greater than the permeability to oxygen. The invention is particularly useful for making sachets in order to conserve fresh fruit, vegetables or meat.
    Type: Grant
    Filed: April 10, 1996
    Date of Patent: March 30, 1999
    Assignee: Elf Atochem S.A.
    Inventors: Alain Frey, Roland Leroux, Laurent Fischer
  • Patent number: 5869414
    Abstract: The invention relates to a breathing film constituting a mixture including:(a) at least one thermoplastic elastomer which has polyether blocks;(b) at least one copolymer including ethylene and at least one alkyl (meth)acrylate.They can be used in combination with fabrics or with nonwovens.
    Type: Grant
    Filed: May 27, 1998
    Date of Patent: February 9, 1999
    Assignee: Elf Atochem S.A.
    Inventors: Laurent Fischer, Michel Degrand, Alain Bouilloux, Jean-Claude Jammet, Yves Germain
  • Patent number: 5840807
    Abstract: The invention relates to a packaging comprising a thermoplastic film based on a polymer containing polyamide blocks and polyether blocks, said polymer being permeable to water vapor, to ethylene, to CO.sub.2 and to oxygen, such that the permeability to CO.sub.2 is very much greater than the permeability to oxygen. The invention is particularly useful for making sachets in order to conserve fresh fruit, vegetables or meat.
    Type: Grant
    Filed: December 13, 1996
    Date of Patent: November 24, 1998
    Assignee: Elf Atochem S.A.
    Inventors: Alain Frey, Roland Leroux, Laurent Fischer
  • Patent number: 5800928
    Abstract: The invention relates to a breathing film constituting a mixture including:(a) at least one thermoplastic elastomer which has polyether blocks;(b) at least one copolymer including ethylene and at least one alkyl (meth)acrylate.They can be used in combination with fabrics or with nonwovens.
    Type: Grant
    Filed: June 19, 1995
    Date of Patent: September 1, 1998
    Assignee: Elf Atochem S.A.
    Inventors: Laurent Fischer, Michel Degrand, Alain Bouilloux, Jean-Claude Jammet, Yves Germain